Skip to main content
Lotus Pharm logo

Lotus Pharm — Investor Relations & Filings

Ticker · 1795 ISIN · TW0001795003 LEI · 984500BEECDBC04KP716 TW Manufacturing
Open in API
Filings indexed 2,730 across all filing types
Latest filing 2026-01-06 Regulatory Filings
Country TW Taiwan
Listing TW 1795

About Lotus Pharm

http://www.lotuspharm.com.tw

Lotus Pharmaceutical Co., Ltd. is a global specialty organization focused on the development, manufacturing, and commercialization of high-barrier generic and specialty medicines. The company specializes in complex generics, with a primary focus on oncology, immunology, and addiction treatment. Its portfolio includes technically demanding products such as Lenalidomide, Suboxone, Nintedanib, and Vinorelbine, as well as an advancing pipeline of biosimilars and 505(b)(2) oncology candidates. Utilizing an integrated R&D and manufacturing platform, the company executes a "2x2" growth strategy centered on dual market expansion and product diversification. Its commercial footprint spans over 90 markets globally, maintaining a strong presence in the Asia-Pacific region and the United States. The company prioritizes high technical entry barriers and cost-effective therapeutic solutions to improve global patient access to essential medications.

Recent filings

Filing Released Lang Actions
功能性委員會成員
Regulatory Filings Classification · 95% confidence The document is very short (280 characters) and contains a table with company code, name, establishment date, and member list. It appears to be a basic disclosure of company information or board members but does not contain any financial data, report content, or detailed announcements. It does not fit into detailed report categories like Annual Report or Interim Report. It is not a certification or legal proceeding. Given the brevity and nature, it is best classified as a Regulatory Filing (RNS), which is the fallback for miscellaneous filings that do not fit other categories.
2026-01-06 Chinese
澄清媒體報導
Regulatory Filings Classification · 95% confidence The document is a short announcement (764 characters) from a listed company (美時化學製藥股份有限公司) clarifying media reports about future revenue and profit expectations. It explicitly states that the company has not prepared any financial forecasts or disclosed profit expectations and advises relying on official disclosures. There are no financial statements, detailed financial data, or comprehensive reports included. The document serves as a regulatory clarification or statement rather than a financial report or detailed filing. It fits best under Regulatory Filings (RNS) as a general regulatory announcement clarifying information to the market.
2025-12-29 Chinese
公告本公司董事會決議辦理限制員工權利新股收 回註銷減資事宜
Share Issue/Capital Change Classification · 95% confidence The document is a public announcement from a listed company (1795 美時) regarding a board resolution to cancel and reduce capital due to the recall of restricted employee shares. It includes details such as the date of the board resolution, amount of capital reduction, number of shares canceled, and other related information. The content is about a capital structure change specifically related to share cancellation and capital reduction. It is not a full financial report, audit, or earnings release, nor is it a meeting presentation or voting result. The document is an official announcement of a capital change event, fitting the category of Share Issue/Capital Change (SHA). The document length is short and contains substantive details about the capital change, not just a notice of report publication or certification, so it is not RPA or RNS.
2025-12-18 Chinese
114年11月背書保證與資金貸與
Regulatory Filings Classification · 90% confidence The document is a financial disclosure from a listed company (美時) providing information about fund loans and endorsement guarantees for the current and previous months, including amounts and limits. It is a short report (619 characters) focused on specific financial data related to loans and guarantees, without comprehensive financial statements or management discussion. It does not announce a report publication or contain officer certifications. The content fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement about financial status without being a full financial report or other specific filing type.
2025-12-10 Chinese
114年11月營業收入
Regulatory Filings Classification · 95% confidence The document is a summary report of monthly and cumulative revenue figures for a company named 美時, presented in a tabular format with explanations about accounting standards and reporting practices. It contains no detailed financial statements, management discussion, or comprehensive analysis. The length is short (778 characters), and it appears to be a regulatory disclosure of revenue figures rather than a full financial report or earnings release. There is no indication of an earnings announcement or detailed quarterly report, nor is it a notice of dividend, capital change, or other corporate action. Given the nature and length, this fits best as a Regulatory Filing (RNS) which is a general category for miscellaneous regulatory disclosures that do not fit other specific categories.
2025-12-10 Chinese
代重要子公司Lotus International Pte.Ltd.公告2025年 股東臨時會重要決議事項
Regulatory Filings Classification · 95% confidence The document is a brief announcement from a listed company (1795 美時) regarding an important resolution made at a shareholders' extraordinary meeting of its subsidiary Lotus International Pte.Ltd. The key resolution mentioned is a capital reduction. The document is very short (508 characters) and serves as a notification of the meeting's outcome rather than a detailed report or financial statement. It does not contain financial data or detailed analysis, nor is it a full report or presentation. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about corporate actions without detailed financial content or formal report structure.
2025-12-05 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.